EnGeneIC
is an Australia-based biopharmaceutical company that develops and commercializes therapies for the treatment of cancer and infectious diseases... Read moreEnGeneIC
is an Australia-based biopharmaceutical company that develops and commercializes therapies for the treatment of cancer and infectious diseases... Read more
News
Oct 01, 2024
Citybizlist
EnGeneIC: Daniel Von Hoff Joins Scientific/Clinical Advisory Board of EnGeneIC Cancer Therapeutics
Sep 24, 2024
Benzinga
EnGeneIC: EnGeneIC Selects Global CDMO BioCina to Advance Their Ground-Breaking Cancer Treatment
Jun 10, 2024
Pharmabiz
EnGeneIC: US FDA grants fasttrack designation to EnGeneIC's ANDC pancreatic cancer therapeutic
Jun 10, 2024
ChinaBio Today
EnGeneIC: Sydney's EnGeneIC Raises Funds in Singapore for Targeted Nanocell Technology
Jun 07, 2024
Biospectrum Asia
EnGeneIC: Singapore Institute of Advanced Medicine to revolutionise cancer treatment in Asia
Dec 08, 2023
StreetInsider
Press Release: EnGeneIC : EnGeneIC granted FDA "Fast-Track" Designation for Novel Armed Nanocell Drug Conjugate (ANDC) Pancreatic Cancer Therapeutic
Jan 31, 2023
Yahoo
EnGeneIC: EnGeneIC publishes the COVID-EDV vaccine's novel mechanism of action in a leading Immunology journal
Nov 14, 2022
Australian Financial Review
EnGeneIC: Cancer biotech raising $20m after delaying Nasdaq float
Jun 29, 2022
Biospectrum Asia
EnGeneIC: Australia's EnGeneIC brings 2nd-Gen COVID-19 vaccine against all variants
Dec 03, 2021
Startup Daily
EnGeneIC: Sydney biotech matches crowdfunding record with $5 million with Covid vaccine plan
EnGeneIC Competitors
1
2
3
4
5
6
7
8
9
10